Compare FULC & SGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FULC | SGU |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.8M | 410.0M |
| IPO Year | 2019 | 1997 |
| Metric | FULC | SGU |
|---|---|---|
| Price | $6.17 | $12.90 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $16.38 | N/A |
| AVG Volume (30 Days) | ★ 586.4K | 22.9K |
| Earning Date | 04-27-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 5.90% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,784,418,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.70 |
| Revenue Growth | N/A | ★ 1.04 |
| 52 Week Low | $5.90 | $11.31 |
| 52 Week High | $15.74 | $13.53 |
| Indicator | FULC | SGU |
|---|---|---|
| Relative Strength Index (RSI) | 31.50 | 53.53 |
| Support Level | N/A | $12.31 |
| Resistance Level | $7.09 | $12.99 |
| Average True Range (ATR) | 0.41 | 0.35 |
| MACD | -0.07 | 0.00 |
| Stochastic Oscillator | 0.00 | 53.91 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
Star Group LP is a home heating oil and propane distributor and services provider with one reportable operating segment that principally provides heating related services to residential and commercial customers. It serves residential and commercial customers whose primary use is to heat their homes and buildings in the Northeast and Mid-Atlantic U.S. regions. The company derives the majority of revenue from Petroleum products, which consist of home heating oil and propane as well as diesel fuel and gasoline.